Skip to product information
1 of 1

APC-Cy7 Mouse Anti-Human CD279 (PD-1) Antibody (S-R570)

APC-Cy7 Mouse Anti-Human CD279 (PD-1) Antibody (S-R570)

Catalog Number: S0B8811 Application: FCM Reactivity: Human Conjugation: APC-Cy7 Brand: Starter
Price:
Regular price $220 USD
Regular price Sale price $220 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen CD279 (PD-1)
Synonyms Programmed cell death protein 1; Protein PD-1; hPD-1; CD279; PD1; PDCD1
Location Cell membrane
Accession Q15116
Clone Number S-R570
Antibody Type Mouse mAb
Isotype IgG1,k
Application FCM
Reactivity Hu
Positive Sample Human Peripheral Blood cells
Purification Protein G
Concentration 0.2 mg/ml
Conjugation APC-Cy7
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.3% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 1.25μl per million cells in 100μl volume Hu

Background

Programmed cell death protein 1 (PD-1), also known as CD279, is a type I transmembrane protein belonging to the CD28 immunoglobulin superfamily. It is encoded by the Pdcd1 gene and consists of 288 amino acids, including an extracellular IgV-like domain, a transmembrane region, and a cytoplasmic tail. PD-1 is expressed on activated T cells, B cells, macrophages, dendritic cells, and natural killer cells. Its cytoplasmic domain contains two tyrosine residues that form an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM), which play key roles in inhibiting T cell receptor signaling. PD-1 interacts with its ligands PD-L1 and PD-L2 to negatively regulate immune responses, contributing to peripheral tolerance and preventing autoimmune diseases. However, this inhibitory function can also suppress anti-tumor immunity, making PD-1 a promising target for cancer immunotherapy.

Picture

FC

Flow cytometric analysis of human peripheral blood cells. Human Peripheral Blood cells were stained with Brilliant Violet 421™ Mouse Anti-Human CD3 and either APC-Cy7 Mouse IgG1, k Isotype Control (left panel) or SDT APC-Cy7 Mouse Anti-Human CD279 (PD-1) Antibody (right panel) at 1.25 μl/test treated with True-Stain Monocyte Blocker™. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.